Oragenics, Inc.
OGEN
$1.11
-$0.006-0.54%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 31.68% | -79.49% | |||
| Gross Profit | -31.68% | 79.49% | |||
| SG&A Expenses | -24.94% | -0.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.40% | -39.61% | |||
| Operating Income | 15.40% | 39.61% | |||
| Income Before Tax | -2.48% | 33.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.48% | 33.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.48% | 33.80% | |||
| EBIT | 15.40% | 39.61% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 14.98% | 56.70% | |||
| Normalized Basic EPS | 14.98% | 56.70% | |||
| EPS Diluted | 14.98% | 56.70% | |||
| Normalized Diluted EPS | 14.98% | 56.70% | |||
| Average Basic Shares Outstanding | 20.54% | 52.84% | |||
| Average Diluted Shares Outstanding | 20.54% | 52.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||